Direct Biologics, LLC (United States)

Homepage: directbiologics.com

Alternate names: Direct Biologics, Direct Biologics, LLC

ROR: 00z14x915

OpenAlex ID: I4405267048

Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19

2023 · Amy L. Lightner, Vikram Sengupta, et al. · CHEST Journal · 175

Response to Lim et al. re: “Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19”

2020 · Vikram Sengupta, Sascha Sengupta, et al. · Stem Cells and Development · 26

Bone marrow mesenchymal stem cell-derived extracellular vesicle infusion for amyotrophic lateral sclerosis

2024 · Joshua J Crose, Arezou Crose, et al. · Neurodegenerative Disease Management · 21

Safety and Efficacy of Intravenous ExoFlo in the Treatment of Complex Regional Pain Syndrome

2023 · Rick Paicius, Zeyn S White, et al. · Pain Physician · 16

Safety of Bone Marrow Derived Mesenchymal Stem Cell Extracellular Vesicle Injection for Lumbar Facet Joint Pain

2024 · James E Wilson, Bobbie A Today, et al. · Regenerative Medicine · 12

Treatment of severe traumatic brain injury with human bone marrow mesenchymal stem cell extracellular vesicles: a case report

2025 · Thomas S. Nabity, John T. Ransom · Brain Injury · 7

A novel extracellular vesicle paradigm for the treatment of COVID-19 induced acute respiratory distress syndrome (ARDS)

2024 · Erik Osborn, John T. Ransom, et al. · Respiratory Medicine Case Reports · 6

Bone Marrow Mesenchymal Stem Cell Extracellular Vesicle Treatment of Respiratory Failure from COVID-19: Endpoint Analysis of Expanded Access Safety Trial

2026 · Vikram Sengupta, Sascha Qian, et al. · Stem Cell Reviews and Reports · 3

A trial of exosome rich stem cell secretome as a potential treatment for Hypermobile Ehlers-Danlos Syndrome

2026 · Kevin J. Flynn, John T. Ransom, et al. · Frontiers in Medicine

Embryonic, Organ and Other Tissue Specific Stem Cells: BONE MARROW MESENCHYMAL STEM CELL DERIVED EXTRACELLULAR VESICLE INFUSION FOR SEVERE OR CRTIICAL COVID-19 RESPIRATORY FAILURE: A RANDOMIZED CLINICAL TRIAL

2023 · A. Lightner, E. Schmidt, et al. · Cytotherapy

Works count: 10

Citation count: 1,065